Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Barnich

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Cell Host & Microbe|August 7, 2012
Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient miceFrederic A Carvalho, Omry Koren, Julia K Goodrich, et al.
Journal of Crohn'S & Colitis|June 13, 2025
A Randomized Controlled Trial Of Antibiotics Targeting Adherent And Invasive Escherichia Coli (Aiec) Vs Placebo In Crohn's Disease: The Teorem TrialFranck Carbonnel, Nicolas Barnich, Patricia Lepage, et al.
Nature Microbiology|November 6, 2019
Dietary L-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gutSho Kitamoto, Christopher J Alteri, Michael Rodrigues, et al.
Gut Microbes|February 28, 2024
The colibactin-producing <i>Escherichia coli</i> alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistanceNilmara de Oliveira Alves, Guillaume Dalmasso, Darja Nikitina, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 29, 2026
Development and external validation of a predictive model for postoperative recurrence of Crohn's disease in the biologic eraMatthieu Allez, Michiel T J Bak, Sofia Brand, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Cell Host & Microbe|August 7, 2012
Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient miceFrederic A Carvalho, Omry Koren, Julia K Goodrich, et al.
Journal of Crohn'S & Colitis|June 13, 2025
A Randomized Controlled Trial Of Antibiotics Targeting Adherent And Invasive Escherichia Coli (Aiec) Vs Placebo In Crohn's Disease: The Teorem TrialFranck Carbonnel, Nicolas Barnich, Patricia Lepage, et al.
Nature Microbiology|November 6, 2019
Dietary L-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gutSho Kitamoto, Christopher J Alteri, Michael Rodrigues, et al.
Gut Microbes|February 28, 2024
The colibactin-producing <i>Escherichia coli</i> alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistanceNilmara de Oliveira Alves, Guillaume Dalmasso, Darja Nikitina, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 29, 2026
Development and external validation of a predictive model for postoperative recurrence of Crohn's disease in the biologic eraMatthieu Allez, Michiel T J Bak, Sofia Brand, et al.
Pageof 16